| ecDNA hubs drive cooperative intermolecular oncogene expression KL Hung, KE Yost, L Xie, Q Shi, K Helmsauer, J Luebeck, R Schöpflin, ... Nature 600 (7890), 731-736, 2021 | 153 | 2021 |
| Current and future treatment strategies for rhabdomyosarcoma C Chen, H Dorado Garcia, M Scheer, AG Henssen Frontiers in oncology 9, 1458, 2019 | 138 | 2019 |
| Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma K Helmsauer, ME Valieva, S Ali, R Chamorro González, R Schöpflin, ... Nature communications 11 (1), 5823, 2020 | 129 | 2020 |
| Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia S Takao, L Forbes, M Uni, S Cheng, JMB Pineda, Y Tarumoto, P Cifani, ... Elife 10, e65905, 2021 | 37 | 2021 |
| Principles of ecDNA random inheritance drive rapid genome change and therapy resistance in human cancers JT Lange, CY Chen, Y Pichugin, L Xie, J Tang, KL Hung, KE Yost, Q Shi, ... BioRxiv, 2021.06. 11.447968, 2021 | 16 | 2021 |
| Therapeutic targeting of ATR in alveolar rhabdomyosarcoma H Dorado García, F Pusch, Y Bei, J von Stebut, G Ibáñez, K Guillan, ... Nature Communications 13 (1), 4297, 2022 | 10 | 2022 |
| Exploiting a PAX3-FOXO1-induced synthetic lethal ATR dependency for rhabdomyosarcoma therapy HD García, Y Bei, J von Stebut, G Ibáñez, K Imami, D Gürgen, J Rolff, ... bioRxiv, 2020.12. 04.411413, 2020 | 1 | 2020 |
| Therapeutic remodeling of CBP transcription factor complex controls oncogenic gene expression in acute myeloid leukemia L Forbes, P Cifani, G Minuesa, C Chen, S Takao, MG Kharas, RP Koche, ... bioRxiv, 2020 | | 2020 |
